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A B S T R A C T
It is imperative to have evidence-based guidelines for cesarean delivery. The aim of this meta-analysis
was to evaluate the effectiveness of a cephalad–caudad compared to transverse blunt expansion of the
uterine incision to reduce blood loss in women who underwent low-segment transverse cesarean
delivery. We therefore performed a systematic search in electronic databases from their inception until
March 2016. We included all randomized trials comparing cephalad–caudad versus transverse (control
group) blunt expansion of the uterine incision in women who underwent a low transverse cesarean
delivery. The primary outcome was postpartum blood loss, deﬁned as the mean amount of blood loss
(mL). Two trials (921 women) were analyzed. After the transverse uterine incision in the lower uterine
segment with the scalpel, the uterine incision was then bluntly expanded by the designated method.
Blunt expansion of the primary incision was derived by placing the index ﬁngers of the operating
surgeon into the incision and pulling the ﬁngers apart laterally (transverse group) or cephalad
(cephalad–caudad group). Women who were randomized in the cephalad–caudad group had lower:
mean of postpartum blood loss, hemoglobin drop and hematocrit drop 24 h after cesarean, unintended
extension, uterine vessels injury, blood loss >1500 mL and need for additional stitches. There was no
statistically signiﬁcant difference in the incidence of blood loss >1000 mL, in the operating time and in
post-operative pain. In conclusion, expansion of the uterine incision with ﬁngers in a cephalad–caudad
direction is associated with better maternal outcomes and, therefore, should be preferred to transverse
expansion during a cesarean delivery.
 2016 Elsevier Ireland Ltd. All rights reserved.
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Cesarean delivery (CD) is one of the most common surgical
procedures performed in the Western world and rates are
increasing despite efforts to the contrary [1]. It is imperative to
have evidence-based guidelines for each surgical step, in order
to minimize morbidity and mortality [2,3].
The most common complication of CD is hemorrhage [2].
Researchers have identiﬁed the following surgical steps as crucial
moments for reducing blood loss during the operative abdominal
delivery: use of uterotonics, spontaneous placental removal and
blunt expansion of the uterine incision with ﬁngers, rather than
scissors [3]. Indeed, compared to sharp uterine incision expansion,
blunt expansion is associated with less unintended extensions
and favorable maternal outcomes [3]. However, whether the blunt
expansion of uterine incision should be performed cephalad–
caudally or transversely is still a matter of debate.
The aim of this study was to evaluate the effectiveness of a
cephalad–caudad compared to transverse blunt expansion to
reduce blood loss in women undergoing a low-segment transverse
CD.
Materials and methods
This review was performed according to a protocol designed
a priori and recommended for systematic review [4]. Electronic
databases (i.e. MEDLINE, PROSPERO, Scopus, ClinicalTrials.gov,
EMBASE, Sciencedirect, the Cochrane Library, Scielo) were
searched from their inception until March 2016. Search terms
used were the following text words: ‘‘cesarean,’’ ‘‘caesarean’’,
‘‘cephalad–caudad blunt expansion’’, ‘‘transverse blunt expan-
sion’’, ‘‘expansion of uterine incision’’, ‘‘obstetric haemorrhage’’,
‘‘randomized,’’ ‘‘randomized controlled trial’’ and ‘‘randomized
clinical trial.’’ No restrictions for language or geographic location
were applied. In addition, the reference lists of all identiﬁed articles
were examined to identify studies not captured by electronic
searches. The electronic search and the eligibility of the studies
were independently assessed by two authors (SX, VB). Differences
were discussed and consensus reached.
We included all randomized clinical trials (RCTs) comparing
cephalad–caudad (i.e. intervention group) versus transverse (i.e.
control group) blunt expansion in women who underwent a low-
segment transverse CD. Selection included women undergoingFig. 1. The transverse (A) or cephalad–caudad (B) blunt expansion oa low-segment transverse CD after 30 weeks of gestation, either
planned or urgent. Quasi-randomized trials (i.e. trials in which
allocation was done on the basis of a pseudo-random sequence,
e.g. odd/even hospital number or date of birth, alternation) were
excluded.
After the transverse uterine incision in the lower uterine
segment with the scalpel, the uterine incision was then bluntly
expanded by the designated method. Blunt expansion of the
primary incision was derived by placing the index ﬁngers of the
operating surgeon into the incision and pulling the ﬁngers apart
laterally (i.e. transverse group) or cephalad–caudad (i.e. cephalad–
caudad group). Women in the transverse expansion group had
the uterine incision extended by the insertion of both index ﬁngers
of the operator into the opening who then pulled the ﬁnger apart
laterally. In the cephalad–caudad expansion group, a transverse
opening of the lower uterine segment was created by separation
of the ﬁngers of the surgeon in a cephalad–caudad direction along
the midline (Fig. 1).
The risk of bias in each included study was assessed by using
the criteria outlined in the Cochrane Handbook for Systematic
Reviews of Interventions. Seven domains related to risk of bias
were assessed in each included trial since there is evidence that
these issues are associated with biased estimates of treatment
effect: (1) random sequence generation; (2) allocation conceal-
ment; (3) blinding of participants and personnel; (4) blinding of
outcome assessment; (5) incomplete outcome data; (6) selective
reporting; and (7) other bias. Review authors’ judgments were
categorized as ‘‘low risk’’, ‘‘high risk’’ or ‘‘unclear risk’’ of bias [4].
Two authors (SX, GS) independently assessed inclusion criteria,
risk of bias and data extraction. Disagreements were resolved by
consensus with a third reviewer (VB). Data from each eligible
study were extracted without modiﬁcation of original data onto
custom-made data collection forms. Differences were reviewed,
and further resolved by common review of the entire process. Data
not presented in the original publications were requested from
the principal investigators.
All analyses were done using an intention-to-treat approach,
evaluating women according to the treatment group to which
they were randomly allocated in the original trials. Primary and
secondary outcomes were deﬁned before data extraction. The
primary outcome was postpartum blood loss, deﬁned as the mean
amount of blood loss (mL) in case of CD. Secondary outcomes
included incidence of unintended extension, uterine vessels injury,f the low transverse uterine incision during cesarean delivery.
Fig. 2. Flow diagram of studies identiﬁed in the systematic review. (Prisma template
[Preferred Reporting Item for Systematic Reviews and Meta-analyses]). RCTs,
randomized controlled trials.
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hemoglobin (Hgb) and hematocrit (Hct) drop 24 h after CD, mean
of operating time (min) and post-operative pain.
The data analysis was completed independently by two authors
(SX, GS) using Review Manager v. 5.3 (The Nordic Cochrane Centre,
Cochrane Collaboration, 2014, Copenhagen, Denmark). The com-
pleted analyses were then compared, and any difference was
resolved by consensus with a third reviewer (VB). Statistical
heterogeneity across studies was assessed using the Higgins I2 test.
In case of statistically signiﬁcant heterogeneity (I2 > 0%) the
random effects model of DerSimonian and Laird was managed;
otherwise, in case of no inconsistency in the risk estimates (I2 = 0),
a ﬁxed effect model was performed [4]. The summary measures
were reported as mean difference (MD) or as relative risk (RR) with
95% of conﬁdence interval (CI). Potential publication biases were
statistically assessed by using Begg’s and Egger’s tests. p Value
<0.05 was considered statistically signiﬁcant.
The meta-analysis was reported following the Preferred
Reporting Item for Systematic Reviews and Meta-analyses
(PRISMA) statement [5]. Before data extraction, the review was
registered with the PROSPERO International Prospective Register
of Systematic Reviews (registration No.: CRD42015027791)
following the PRIMA guidelines for protocols (PRIMSA-P) [6].
Results
The ﬂow of study identiﬁcation is shown in Fig. 2. Three RCTs
were assessed for eligibility [7–9]. One was excluded since blunt
versus sharp uterine incision expansion was evaluated [9]. Two
RCTs, including 921 women, were analyzed [7,8]. Of the
921 included women, 459 (50%) were randomized in the
cephalad–caudad group, while 462 (50%) in the transverse group
(i.e. control group). Publication bias, assessed statistically by using
Begg’s and Egger’s tests, showed no signiﬁcant bias (p = 0.21 and
p = 0.34, respectively). The quality of the studies included in our
meta-analysis was assessed by using the criteria outlined in the
Cochrane Handbook for Systematic Reviews of Interventions
(Fig. 3) [4]. All the included studies had low risk of bias in
‘‘random sequence generation.’’ Adequate methods for allocation
of women were used in both RCTs. Blinding was considered not
feasible methodologically given the intervention, and therefore
none of the included studies was double blind. Both authors (AC,
PO) of the original RCTs kindly provided additional unpublished
data.
Table 1 shows the characteristics of the two included studies
and of the 921 included women. No differences were found in the
maternal characteristics between the two groups. Both studies
came from Europe. In these two RCTs women who underwent a
low-segment transverse CD were assigned randomly to have the
blunt expansion of the uterine incision by the physician separating
the ﬁngers either in a transverse direction or in a cephalad–caudad
direction. In the Italian RCT the primary outcome was the incidence
of unintended extensions [7], while Ozcan et al. did not pre-
speciﬁed the primary outcome [8]. All operations were performed
under spinal anesthesia and skin incisions were made with a
classical Pfannenstiel incision. The two studies had different
inclusion criteria: Cromi et al. enrolled all women who underwent
a low-segment transverse CD after 30 weeks of gestation, either
planned or urgent [7], while Ozcan et al. excluded women with
severe medical conditions [8]. One RCT included only singleton
gestations [8]. In the Italian trial blood loss was estimated from the
blood that had been collected in the suction device, in the plastic
pouches of sterile drapes, and in the saturation of pads and sponges
[7]. In the study by Ozcan et al. blood loss was estimated using the
weight of compresses using during the CD (the increase in weightof compresses with absorbed blood) and the number of
intraoperative compresses [8].
Table 2 shows pooled results of the primary and secondary
outcomes. The statistical heterogeneity across studies was low,
with no inconsistency (I2 = 0) in risk estimates for the primary
outcome and for most of the secondary outcomes. Women who
were randomized in the cephalad–caudad group had lower: mean
of postpartum blood loss (MD 67.64 mL, 95% CI 102.85 to
32.43; Fig. 4), Hgb drop (MD 0.26 g/dL, 95% CI 0.37 to 0.14)
and Hct drop 24 h after CD (MD 1.20 g/dL, 95% CI 1.87 to 0.53),
unintended extension (4.8% vs. 8.9%; RR 0.51, 95% CI 0.30–0.88),
uterine vessels injury (1.5% vs. 2.8%; RR 0.52, 95% CI 0.20–0.84),
blood loss >1500 mL (0.2% vs. 1.7%; RR 0.12, 95% CI 0.02–0.99)
and need for additional stitches (20.3% vs. 29.2%; RR 0.60, 95% CI
0.44–0.82). There was no statistically signiﬁcant difference in the
incidence of blood loss >1000 mL (1.2% vs. 3.0%; RR 0.41, 95% CI
0.14–1.18), in the operating time (MD 1.36 min, 95% CI 0.17 to
2.89) and in post-operative pain (0.50 points, 95% CI 1.17 to
0.17) (Table 2).
Comment
This meta-analysis from the two high-quality low risk of bias
RCTs, including 921 women undergoing a low-segment transverse
Fig. 3. Assessment of risk of bias. (A) Summary of risk of bias for each trial; plus sign: low risk of bias; minus sign: high risk of bias; question mark: unclear risk of bias. (B) Risk
of bias graph about each risk of bias item presented as percentages across all included studies.
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transverse uterine incision decreased blood loss compared to
transverse blunt expansion. It was also associated with lower drop
of Hgb and Hct 24 h after CD and lower risk of unintended
extension, uterine vessels injury and need for additional stitches.
The comparison of blunt and sharp expansion of the low
transverse uterine incision has commonly been discussed in the
literature [9–17]. Results from a Cochrane review suggest that
blunt expansions should be preferred over sharp expansions
because blunt expansions appear to be associated with lower riskTable 1
Characteristics of the included trials and of the included women.
Cromi 2008 [7] 
Study location Italy 
Number of patients 811 (405 vs. 406) 
Inclusion criteria Women who underwent a low transve
cesarean delivery after 30 weeks of ge
either planned or urgent
Maternal age 32.6  4.9 vs. 32.7  4.8 
Parity 0.4  0.6 vs. 0.5  0.7b
Nulliparous 344 (84.9%) vs. 351 (86.5%)a
Primigravida 240 (59.3%) vs. 261 (64.3%)a
Previous CD 104 (25.7%) vs. 90 (22.2%) 
BMI 26.7  4.0 vs. 27.3  4.2 
GA at birth (weeks) 38.3  2.4 vs. 38.5  2.6 
Labor stage
Not in labor 274 (67.7%) vs. 296 (72.9%) 
First stage 64 (15.8%) vs. 46 (11.3%) 
Second stage 67 (16.5%) vs. 64 (15.8%) 
Indication for cesarean
Prior cesarean 101 (24.9%) vs. 89 (21.9%) 
Dystocia 88 (21.7%) vs. 87 (21.4%) 
Fetal distress 87 (21.5%) vs. 91 (22.4%) 
Malpresentation 57 (14.1%) vs. 62 (15.3%) 
Other 72 (17.8%) vs. 77 (18.9%) 
Fetuses’ birth weight 3112  588 vs. 3150  554 
Fetuses with macrosomia 17 (4.2%) vs. 15 (3.7%) 
Primary outcome Incidence of unintended extensions 
Data are presented as total number (number in the cephalad–caudad group vs number in
no previous vaginal delivery; Primigravida, no previous pregnancy; BMI, body mass index
a Additional unpublished data kindly obtained by the authors of the original trials.
b Severe medical conditions: diabetes mellitus, moderate-severe hypertension, any
pregnancies, suspected macrosomia, polyhydramnios), emergency surgery (placenta a
abdominal surgeries.of blood loss, shorter operative time, and less unintended
extension [17]. It remained, however, unclear which type of blunt
technique – cephalocaudal versus transverse – should be used. To
our knowledge, ours is the ﬁrst meta-analysis evaluating the
effectiveness of cephalad–caudad compared to transverse blunt
expansion to reduce blood loss in women who underwent a low
transverse CD.
Our study has several strengths. The two included studies had a
low risk of allocation bias by Cochrane Collaboration tool
assessment. Intent-to-treat analysis was used, and both randomOzcan 2015 [8]
Turkey
110 (54 vs. 56)
rse
station,
Singletons without severe medical conditionsb
who underwent a low transverse cesarean delivery
30.4  4.6 vs. 29.7  5.6
1.3  1.4 vs. 1.2  1.0
3 (5.6%) vs. 6 (10.7%)
N/R
42 (77.8%) vs. 46 (82.1%)a
28.1  2.3 vs. 28.7  1.8
38.5  1.1 vs. 38.7  1.1
49 (90.7%) vs. 52 (92.9%)a
5 (9.3%) vs. 4 (7.1%)a
0 vs. 0a
42 (77.8%) vs. 46 (82.1%)a
5 (9.3%) vs. 4 (7.1%)a
0 vs. 0a
7 (13.0%) vs. 6 (10.7%)a
0 vs. 0a
3328  517 vs. 3470  518
0 vs. 0a
N/R
 the transverse group) with percentage or as mean  standard deviation. Nulliparous,
; GA, gestational age; CD, cesarean delivery; N/R, data not recorded.
 blood or thrombophilia disorders, presence of uterine overdistension (multiple
bruption, placenta previa), anti-coagulation therapy or a history of other major
Fig. 4. Forest plot of the mean of estimated blood loss (mL) in case of cesarean delivery. IV, independent variable; CI, conﬁdence interval.
Table 2
Primary and secondary outcomes.
Cromi 2008 [7] Ozcan 2015 [8] Total I2 (%) RR or MD (95% CI)
Estimated blood loss (mL)b 398  242 vs. 440  341 407  196 vs. 551  179a – 0 S67.64 mL (S102.85 to S32.43)
Unintended extension 15/405 (3.7%) vs. 30/406 (7.4%) 7/54 (12.9%) vs. 11/56
(19.6%)
22/459 (4.8%) vs. 41/462
(8.9%)
0 0.51 (0.30–0.88)
Uterine vessels injury 0/405 vs. 2/406 (0.5%) 7/54 (12.9%) vs. 11/56
(19.6%)
7/459 (1.5%) vs. 13/462
(2.8%)
0 0.52 (0.20–0.84)
Need for additional stitches 93/405 (23.0%) vs. 135/406 (33.3%) 0/54 vs. 0/56 93/459 (20.3%) vs. 135/462
(29.2%)
0 0.60 (0.44–0.82)
Blood loss >1000 mL 5/405 (1.2%) vs. 12/406 (3.0%)a N/R 5/405 (1.2%) vs. 12/406
(3.0%)
0 0.41 (0.14–1.18)
Blood loss >1500 mL 1/405 (0.2%) vs. 8/406 (2.0%) 0/54 vs. 0/56 1/459 (0.2%) vs. 8/462
(1.7%)
0 0.12 (0.02–0.99)
Hb drop 24 h after CD (g/dL) 1  0.8 vs. 1.2  1.0 0.9  0.7 vs. 1.4  0.7 – 7 S0.26 g/dL (S0.37 to S0.14)
Hct drop 24 h after CD (g/dL) N/R 2.9  1.8 vs. 4.1  1.8 – 0 S1.20 g/dL (S1.87 to S0.53)
Operating time (min) 40.4  11.8 vs. 38.9  11.9 42.3  11.6 vs. 42  12.1 – 0 1.36 min (S0.17 to 2.89)
Post-operative pain N/R 4.6  1.8 vs. 5.1  1.8 – 0 S0.50 points (S1.17 to 0.17)
Boldface data, statistically signiﬁcant. Data are presented as total number (number in the cephalad–caudad group vs. number in the transverse group) with percentage or as
mean  standard deviation. RR, relative risk; MD, mean difference; CI, conﬁdence interval; Hb, hemoglobin; Hct, hematocrit; post-operative pain, evaluated by the faces pain rating
scale 24 h after the operation; CD, cesarean delivery; h, hours; N/R, data not recorded.
a Additional unpublished data kindly obtained by the authors of the original trials.
b Primary outcome.
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publication bias was not apparent by statistical analysis. Hetero-
geneity between studies was variable but generally was not
signiﬁcant. These are key elements that are needed to evaluate
the reliability of a meta-analysis [4]. We pooled data from due
different RCTs in order to draw conclusions to this clinical
dilemma.
Limitations of our study are mostly inherent to the limitations
of the included studies. The two trials included had somewhat
different inclusion criteria. Given the intervention, none of the
included RCTs was double-blind. The outcome parameters were
not measured with a valid score. The low number of the included
trials and the heterogeneity in terms of rate of prior CD are other
shortcomings of this meta-analysis. Another signiﬁcant concern
was the pre-speciﬁed primary outcome (i.e. estimated blood loss),
which is difﬁcult to measure accurately and consistently, and
where the assessor is not blinded to the allocation.
There are clinical scenarios which were not addressed in the
included RCTs. These include, as examples, a small low uterine
segment (e.g. in preterm gestations), the presence of myomata at
the level of the uterine incision, placenta previa or accreta, or
uterine dehiscence. In general, we would speculate that cephalad–
caudad expansion would still be feasible and preferred in most
(if not all) of these scenarios, but more data is needed for a
deﬁnite answer. The long-term risks of previa or accreta or other
complications in a subsequent pregnancy according to the type of
uterine expansion were also not reported in the included RCTs.
The lower uterine segment consists of circular and transversely
running muscular bundles. This anatomical feature explains why
the uterine incision can be easy widened. When the surgeon
expands laterally the uterine incision, he actually applies a
separating force to the cleavage planes between the muscular
bundles. In order to avoid the consequence deriving from the lackof control of magnitude’s force and the following unintended
extension with possible uterine vessel injury, the cephalad–caudad
expansion has been proposed. Our meta-analysis showed that
cephalad–caudad blunt expansion of the low transverse uterine
incision decreased blood loss compared to transverse blunt
expansion. The biological plausibility to explain our ﬁndings is
not completely clear. However, the supposed advantage of the
cephalad–caudad approach might be the control of the expansion,
thus avoiding the damage of lateral uterine and parametrial blood
vessels.
In summary, expansion of the uterine incision in a cephalad–
caudad direction is associated with lower risks of postpartum
blood loss, unintended extension, uterine vessels injury and need
for additional stitches, and should therefore be preferred to
transverse expansion when a CD is performed. Further studies are
required concerning subsequent pregnancies, e.g. risk of scar
dehiscence during a vaginal birth after cesarean, risk of placenta
previa/accreta in the next pregnancy.
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